> A new report written in part by Europol takes India to task for not doing more to interrupt the manufacture of counterfeit meds that are ending up in Europe. Report
> CPhI has added Kurt Nielson of Catalent ($CTLT); Vivek Sharma of Piramal; and Alan Sheppard of IMS Health ($IMS) to its panel of experts for evaluating supply-chain trends. Release
> The European Federation of Pharmaceutical Industries and Associations says more flexibility in the EU's GMP guidance on qualification and validation would promote new technologies in the future. Report